Related Experiment Video

Updated: Apr 5, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

511

Clinical Potential of microRNA-7 in Cancer

Jessica L Horsham1,2, Felicity C Kalinowski3, Michael R Epis4

  • 1Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, The University of Western Australia Centre for Medical Research, Perth, WA 6000, Australia. jessica.horsham@perkins.uwa.edu.au.

Journal of Clinical Medicine
|August 27, 2015
PubMed

Insights

MicroRNA-7 (miR-7) primarily functions as a tumor suppressor, inhibiting cancer progression. However, its dual role in cancer warrants further investigation for biomarker and therapeutic applications.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are short, non-coding RNA molecules regulating gene expression post-transcriptionally.
  • miRNAs are implicated in cellular processes, homeostasis, and diseases, notably cancer.
  • miRNA-7 (miR-7) is recognized for its tumor-suppressive functions.

Purpose of the Study:

  • To review the multifaceted role of miR-7 in cancer.
  • To explore miR-7's potential in miRNA-based replacement therapy.
  • To assess miR-7 as a diagnostic and prognostic biomarker.

Main Methods:

  • Literature review of studies on miR-7 in cancer.
  • Analysis of miR-7's direct oncogenic targets.
  • Evaluation of in vitro and in vivo cancer models involving miR-7.

Main Results:

  • miR-7 directly targets and inhibits multiple oncogenic factors.
  • Evidence supports miR-7's role in impeding cancer progression.
  • Some studies suggest potential oncogenic roles for miR-7.

Conclusions:

  • miR-7 exhibits significant tumor-suppressive activity.
  • miR-7 holds promise as a biomarker and therapeutic target in oncology.
  • Further research is needed to fully elucidate miR-7's complex roles in cancer.
Keywords:
biomarkercancermicroRNA replacement therapymicroRNA-7tumour suppressor

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K